The transport of [U-14C] 
INTRODUCTION
In the central nervous system (CNS), nucleosides have a number of important functions. First, they serve as precursors for nucleic acid synthesis. In the case of pyrimidine nucleosides (uridine and cytidine) present in the CNS these must be either derived from the reutilization of nucleoside or transported from the periphery, since the brain lacks the complete enzymic pathways for pyrimidine synthesis (Mcllwain & Bachelard, 1971) . Secondly, there is a large body of evidence suggesting that the nucleoside adenosine is a neuromodulator of CNS functions Stone, 1981) and that transport of adenosine into surrounding cells is an important factor in terminating the action of adenosine (for a review, see . Despite the importance of nucleoside transport in the CNS, our understanding of the mechanism(s) is limited and confused.
Much of this confusion is due to the inability of earlier investigations to distinguish between transport per se and transport plus metabolism. For example, the transport of adenosine by rat brain synaptosomes, and the effect of a wide range of compounds on this process, have been studied by measuring the cellular accumulation of radioactivity after incubation of the tissue with radioactively labelled adenosine (Bender et al., 1980 (Bender et al., , 1981a (Bender et al., ,b, 1982 ; . However, the incubation times used in these studies (30 s up to 15 min at 37°C) were such that the level of accumulation of cellular radioactivity reflected transport, metabolism and backflux of adenosine and metabolic products. Thus, to date, no detailed studies measuring the kinetic properties of nucleoside transport in synaptosomes have been per- formed.
An alternative approach for studying facilitateddiffusion nucleoside transport in brain, involves the use of [3H]NBMPR, a potent specific inhibitor of facilitateddiffusion nucleoside transport in many cell types, as a binding probe (Young & Jarvis, 1983) . Site-specific highaffinity NBMPR-binding sites are present in rat brain membrane preparations (Marangos et al., 1982; Verma & Marangos, 1985; Hammond & Clanachan, 1985; Geiger et al., 1985) , and [3H]NBMPR has been used to localize transport sites by autoradiography (Geiger & Nagy, 1984; Bisserbe et al., 1985) . Nevertheless, conclusions based on these findings concerning nucleoside transport rely on the assumptions that: (a) there is only a single facilitated-diffusion transport system that is sensitive to inhibition by NBMPR, and (b) NBMPR-binding-site occupancy results in inhibition ofnucleoside transport. Such assumptions have not been tested experimentally, and the recent observations that there exist nucleoside-transport systems that are totally or partially resistant to inhibition by NBMPR further emphasize the need to do so (Belt, 1983; Plagemann & Wohlhueter, 1985; Jarvis & Young, 1986) . Indeed, a recent study using guinea-pig brain slices has shown that NBMPR only inhibits about 50 % of the accumulation of adenosine (transport of adenosine and its subsequent metabolism), leading to the suggestion of separate NBMPR-sensitive and -insensitive adenosineuptake sites in the CNS (Davies & Hambley, 1986 Bisserbe et al., 1986) . NBMPR only inhibited 50 % of the [3H]dipyridamole binding, but the nature of NBMPR-insensitive dipyridamole-binding sites has not been investigated.
The objectives of the present study were therefore to assess the kinetic properties of nucleoside transport in rat cerebral-cortical synaptosomes using an inhibitor-stop filtration method to measure initial rates of nucleoside transport and to determine the degree of sensitivity of transport to NBMPR inhibition. Uridine was used as the permeant because, unlike adenosine, it is poorly metabolized by cortical synaptosomes (see Table 1 below). The present results suggest that uridine transport in rat cerebral-cortical synaptosomes can be described by two components that are distinguishable by their sensitivity to inhibition by NBMPR. The properties of NBMPR binding by rat synaptosomes have also been investigated. A preliminary account of some of the work in the present study has been published in abstract form (Lee & Jarvis, 1986) .
MATERIALS AND METHODS

Synaptosome preparation
Synaptosomes were prepared by the method of Gray & Whittaker (1962) , as modified by White (1975) . All centrifugation steps were undertaken at 4 'C. Briefly, the cerebral cortex from two male Sprague-Dawley rats (200-250 g), killed by decapitation, was removed and homogenized in 30 ml of ice-cold sucrose solution (0.32 M-sucrose/0.1 mM-EDTA/5 mM-Hepes, pH 7.5). The homogenate was centrifuged at 1000 g for 10 min at 4 'C and the supernatant retained. The pellet was washed once with the sucrose solution (1000 g, 10 min), and the supernatant was pooled with that obtained from the first centrifugation. The pooled supernatants were centrifuged at 12 000 g for 20 min. The resultant pellet was resuspended in 6 ml of ice-cold sucrose solution, and 1 ml aliquots were transferred to discontinuous sucrose gradients consisting of 2 ml of 0.8 M-and 2 ml of 1.2 Msucrose that were centrifuged at 150 000 g for 60 min (SW 55 Ti Beckman rotor). The synaptosomal fraction was collected from the 0.8/1.2 M-sucrose interface and diluted slowly to 30 ml with incubation medium, pH 7.5, containing (final concentrations): 120 mM-NaCl, 4.75 mMKCl, 1.18 mM-MgSO4, 1.2 mM-KH2PO4, 1.77 mMCaCl2, 5.5 mM-glucose, 5.8 mM-sucrose and 26 mMNaHCO3 (White, 1975) . The synaptosomal suspension was again centrifuged at 20 000 g for 20 min. Finally, the pellet (synaptosomes) was suspended in ice-cold incubation medium and stored on ice. Relative to the starting homogenate the activity of 2':3'-cyclic nucleotide 3'-phosphohydrolase (a glial-cell marker enzyme) in the synaptosome preparation was reduced 20-fold (Olafson et al., 1969; Bradford, 1986 [S] Km + [S] where V is the initial transport rate and [S] is the permeant concentration; the computer program HYPMIC (Barlow, 1983) was used.
The intrasynaptosomal volume was determined by a centrifugation method, using 3H20 to determine total water space and ['4C]inulin for extracellular-space determination (Minn & Gayet, 1977) . The mean value of the intrasynaptosomal volume was 4.5 + 0.5 ,ul/mg of protein from 16 determinations, a value similar to those published previously (Marchbanks, 1975; Barberis et al., 1981 Synaptosomes were incubated for 10 s, 1 and 30 min with either 5 or 100 /LM-["4C]uridine at 22 'C. To identify the intravesicular products, the incubation was stopped with 1 ml of ice-cold stop solution and the membrane vesicles rapidly centrifuged (12000 g, 15 s). The supernatant was removed, and the pellet was immediately solubilized and deproteinized by the addition of 50 ,ul of ice-cold 70 (w/v) HC104. The precipitate was removed by centrifugation (12000 g, 60 s). To analyse for possible extravesicular products of uridine metabolism, the synaptosomes were centrifuged at the end of the incubation period without dilution. Samples of the synaptosome-free incubation medium were diluted with an equal volume of HC104. Aliquots of both types of acid extract were neutralized with 1 M-KHCO3 and centrifuged (12000 g, 60 s) to remove the precipitate. Supernatant was chromatographed on silica-gel-coated plates impregnated with fluorescent indicator.
The following solvents were used for chromatographic analysis: (a) butan-l-ol/acetone/acetic acid/aq. 500 NH3/water (7:5:3:3:2, by vol.) and (b) butan-l-ol (saturated with water). The standards (uridine, uracil, UMP, UDP and UTP) were co-chromatographed with the samples. After drying, the individual standards were localized under u.v. light. Zones were scraped off the plate into scintillation vials and the remainder of the chromatogram divided into 0.5 cm horizontal strips. Radioactivity in these samples were extracted with 1 ml of water with shaking for at least 15 min before the addition of scintillation fluid. Chemicals Fig. 1 ). These diluted vesicles were then filtered immediately or after a 5-90 s delay. Fig. 1 shows that, when an ice-cold stop solution containing 50 /IM-dipyridamole, a nucleoside transport inhibitor, was used, less than 6 0 of the radioactivity in the synaptosomes was lost after a 20 s delay, the time required to complete the washing and filtration (see the Materials and methods section). By contrast, stop solution at either 4 or 22°C in the absence of dipyridamole resulted in a rapid loss of radioactivity from synaptosomes. These results suggest that no significant loss of 14C label is apparent with the ice-cold stop solution containing 50 ,tM-dipyridamole, and thus this solution was routinely used in the present study.
The data of Fig. 1 ; the present study), only partially inhibited uridine influx. To investigate further the effect of NBMPR and dipyridamole on uridine influx by rat cortical synaptosomes, the dose-response curves for inhibition of uridine transport by these compounds were compared (Fig. 3) . In contrast with that for dipyridamole, the inhibition curve for NBMPR was biphasic; about 30 0 of the transport activity was inhibited by NBMPR, with an IC50 value of 0.5 nm. No further inhibition was observed until the NBMPR concentration exceeded 1 /IM. The wide plateau in the inhibition curve suggests that the inhibition observed at > 1 ,sM-NBMPR occurs by a mechanism different from that involved at lower concentrations of NBMPR. Furthermore, the NBMPR inhibition profile suggests that there may be two mechanisms for uridine transport by rat cerebral-cortical synaptosomes that can be distinguished on the basis of their sensitivity to inhibition by NBMPR. Fig. 3 also demonstrates that the dose-response curve for inhibition of uridine transport by dilazep was also biphasic (approximate IC50 values for the two phases of 0.02 and 2 /M), but not so marked as that observed with NBMPR.
Further characterization of these two transport components was performed using synaptosomes pretreated or not with 500 nM-NBMPR. Transport remaining in the presence of 500 nM-NBMPR was defined as 'NBMPRinsensitive', whereas the difference between transport rates determined in the presence of 500 nM-NBMPR and the total uptake rates represents 'NBMPR-sensitive' transport.
The concentration-dependence of uridine influx in the presence or absence of 500 nM-NBMPR is shown in Fig.   4 . Uptake of ['4C] 17 + 2.6 pmol/s per mg of protein). The saturable NBMPR-sensitive component of Fig. 4 was calculated from the total flux by subtracting the total NBMPRinsensitive flux using NBMPR-treated uridine-transport mechanisms in rat cortical synaptosomes was studied by investigating the effect ofadenosine, iiosine, thymidine, 2-chloroadenosine and guanosine on uridine influx by untreated and NBMPR-treated synaptosomes. Table 2 shows that in both cases 2-chloroadenosine was the most effective inhibitor. The apparent K1 values estimated from the IC50 values for inhibition of uridine influx by the NBMPR-sensitive and NBMPR-insensitive transport mechanisms were respectively 21 and 31 /M for 2-chloroadenosine, 62 and 54/M for adenosine, 200 and 270 gM for thymidine, 350 and 270 /SM for inosine and 330 and 430 /M for guanosine (mean values from three experiments). These results, together with the determination of the Km values for uridine transport, suggest that the NBMPR-sensitive and NBMPR-insensitive components ofnucleoside transport in rat cerebral-cortical synaptosomes exhibit similar affinities.
In the preceding sections the ['4C]uridine associated with the synaptosome has been assumed to be due to transport into the intrasynaptosomal space. It is possible, although highly unlikely, that the radiolabel is only binding to the synaptosome. Thus the uptake of ["C]-uridine at equilibrium (5 min incubation) as a function of medium osmolarity was determined (results not shown). This uptake was quite sensitive to changes in medium osmolarity, sharply decreasing with increases in osmolarity. When extrapolated to infinite medium osmolarity, uptake was negligible and not significantly different from zero. This indicates uptake into an osmotically active intravesicular space without appreciable binding to the surface of the synaptosomes.
With buffers identical with those of the transport assays, Fig. 5 Fig. 6 shows that dilazep was a more effective inhibitor than dipyridamole, with calculated K1 values of 4 and 400 nm for dilazep and dipyridamole respectively, values similar to those calculated for inhibiting NBMPR-sensitive uridine transport (see Fig.  3 ). Adenosine was a more effective inhibitor than uridine, IC50 values being 60 and 700 /SM respectively, a result consistent with the relative affinities of these two nucleosides for NBMPR-sensitive nucleoside transport (see Fig. 4 and (Fig. 7) . In both cases the inhibition profiles were consistent with a 
DISCUSSION
We present here the results of a series of experiments that examined the properties of uridine transport by rat cerebral-cortical synaptosomes. In contrast with earlier studies on adenosine uptake (Bender et al., 1980 (Bender et al., , 198 1a,b, 1982 , we found it necessary to use an ice-cold stop solution containing 50 ,sM-dipyridamole for the rapid filtration transport assays. The earlier studies employed a stop solution composed of buffer at room temperature. Fig. 1 clearly demonstrates that this stop solution was unsatisfactory for quantitative uridine uptake by rat cortical synaptosomes. In addition, these earlier studies also used incubation times that resulted in substantial metabolism of adenosine, thereby complicating the interpretation of the data. The present results were obtained under conditions where initial rates of transport were measured and no metabolism of radioactively labelled uridine was detected. The rates of carrier-mediated uridine transport were calculated after subtraction of the flux measured in the presence of 50 /SM-dipyridamole. This concentration of dipyridamole caused total inhibition of transport activity (see Fig. 3 ).
Moreover, the concentration-dependence of uridine influx in the presence of 50 ,tM-dipyridamole was linear, and no further inhibition occurred after the addition of 20 ,M-NBMPR (Fig. 4) . The magnitude of this linear flux component was not significantly different when 50 mM-dilazep was used instead of dipyridamole. Dilazep was approx. 10-fold more potent an inhibitor of uridine transport by rat synaptosomes than dipyridamole. These data demonstrate that 50 ,uM-dipyridamole blocks carrier-mediated uridine transport by rat cerebralcortical synaptosomes, and therefore it is valid to use this concentration of dipyridamole to correct for nonmediated uridine uptake.
Uptake of uridine by our rat cerebral-cortical synaptosome preparation was found to be into an osmotically active space. Uridine transport was inhibited in a biphasic manner by NBMPR, suggesting two components of nucleoside transport by rat synaptosomes distinguishable on the basis of their sensitivity to inhibition by certain nucleoside-transport inhibitors. The first transport component, which we define as 'NBMPRsensitive', was inhibited by nanomolar concentrations of NBMPR with an estimated apparent K, value of approx. (Marangos et al., 1982; Geiger et al., 1985; Hammond & Clanachan, 1985 (Bender et al., 1981 b; . As stated above, the adenosine-uptake studies by Phillis and colleagues failed to measure initial rates of adenosine transport. The present NBMPRbinding and -transport data also do not support the conclusion of Geiger et al. (1985) that [3H]NBMPR binds to adenosine-preferring transporter sites in rat brain that do not have a broad specificity for nucleosides. However, it does appear from our results that adenosine and 2-chloroadenosine have the highest affinity of the nucleosides tested for the NBMPR-sensitive transporter.
The second uridine-transport component, defined as 'NBMPR-insensitive ', was not inhibited by concentrations of NBMPR as high as 1 ,UM. Similarly, dilazep was also a much less potent inhibitor of this flux component (apparent K1 1.5 /M) compared with inhibition of the NBMPR-sensitive uridine transport by rat cortical synaptosomes. In other respects the two transport components are quite similar. Both mechanisms are facilitated-diffusion systems with similar apparent Km values for uridine (-200 /tM) . Inhibition experiments also suggest that there are no significant differences in the specificity of the two transport components for a variety of nucleosides and that the systems have a broad specificity for both purine and pyrimidine nucleosides. The affinity of the nucleosides, as determined from the inhibition of uridine transport, is similar to that observed in other cells, with adenosine and 2-chloroadenosine having the highest affinity (Young & Jarvis, 1983) . Also, both transporters in rat cerebral-cortical synaptosomes appear to be equally sensitive to inhibition by dipyridamole, as judged from the monophasic curve presented in Fig. 3 . It is unlikely that one of the transport components that we observe in the present study might be of glial origin, because contamination of glial-cell fragments in the synaptosomal fraction, estimated by activities of the glial-cell-specific enzyme 2': 3'-cyclic nucleotide 3'-phosphohydrolase, is only 5 %.
In conclusion, the present results suggest that there are two components of facilitated-diffusion nucleoside transport present in our preparation of rat cerebral-cortical synaptosomes. These two components have similar substrate affinities, but differ in their susceptibility to inhibition by NBMPR. These two transport components may represent the products of separate genes, or alternatively two conformations of a single protein that differ in their ability to bind NBMPR with high affinity.
